Joint Treatment for Psoriasis

Pfizer's Xeljanz gets FDA nod as joint disease treatment for active patients twice a day. Psoriatic arthritis, a form of arthritis that affects people who have skin disease psoriasis, is characterized by symptoms such as joint pain, stiffness and swelling. Click here to learn more about Dupixent and our Psoriasis Program

Read study and article here by Rueters. 

Schedule an appointment with PA-C Amanda Hullett

 

Comments: